The role of activated monocyte IFN/SIGLEC1 signalling in Graves’ disease

in Journal of Endocrinology
Authors:
Yanqiu WangDepartment of Endocrine and Metabolic Diseases, Shanghai Institute of Endocrine and Metabolic Diseases, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
Shanghai National Clinical Research Center for Metabolic Diseases, Key Laboratory for Endocrine and Metabolic Diseases of the National Health Commission of the PR China, Shanghai Key Laboratory for Endocrine Tumor, State Key Laboratory of Medical Genomics, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China

Search for other papers by Yanqiu Wang in
Current site
Google Scholar
PubMed
Close
https://orcid.org/0000-0002-5754-7635
,
Zhou JinDepartment of Endocrine and Metabolic Diseases, Shanghai Institute of Endocrine and Metabolic Diseases, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
Shanghai National Clinical Research Center for Metabolic Diseases, Key Laboratory for Endocrine and Metabolic Diseases of the National Health Commission of the PR China, Shanghai Key Laboratory for Endocrine Tumor, State Key Laboratory of Medical Genomics, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China

Search for other papers by Zhou Jin in
Current site
Google Scholar
PubMed
Close
,
Jiajun SunDepartment of Endocrine and Metabolic Diseases, Shanghai Institute of Endocrine and Metabolic Diseases, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
Shanghai National Clinical Research Center for Metabolic Diseases, Key Laboratory for Endocrine and Metabolic Diseases of the National Health Commission of the PR China, Shanghai Key Laboratory for Endocrine Tumor, State Key Laboratory of Medical Genomics, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China

Search for other papers by Jiajun Sun in
Current site
Google Scholar
PubMed
Close
,
Xinxin ChenDepartment of Endocrine and Metabolic Diseases, The Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou Municipal Hospital, Gusu School, Nanjing Medical University, Shanghai, China

Search for other papers by Xinxin Chen in
Current site
Google Scholar
PubMed
Close
,
Pu XieDepartment of Endocrine and Metabolic Diseases, Shanghai Institute of Endocrine and Metabolic Diseases, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
Shanghai National Clinical Research Center for Metabolic Diseases, Key Laboratory for Endocrine and Metabolic Diseases of the National Health Commission of the PR China, Shanghai Key Laboratory for Endocrine Tumor, State Key Laboratory of Medical Genomics, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China

Search for other papers by Pu Xie in
Current site
Google Scholar
PubMed
Close
,
Yulin ZhouDepartment of Endocrine and Metabolic Diseases, Shanghai Institute of Endocrine and Metabolic Diseases, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
Shanghai National Clinical Research Center for Metabolic Diseases, Key Laboratory for Endocrine and Metabolic Diseases of the National Health Commission of the PR China, Shanghai Key Laboratory for Endocrine Tumor, State Key Laboratory of Medical Genomics, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China

Search for other papers by Yulin Zhou in
Current site
Google Scholar
PubMed
Close
, and
Shu WangDepartment of Endocrine and Metabolic Diseases, Shanghai Institute of Endocrine and Metabolic Diseases, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
Shanghai National Clinical Research Center for Metabolic Diseases, Key Laboratory for Endocrine and Metabolic Diseases of the National Health Commission of the PR China, Shanghai Key Laboratory for Endocrine Tumor, State Key Laboratory of Medical Genomics, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China

Search for other papers by Shu Wang in
Current site
Google Scholar
PubMed
Close
https://orcid.org/0000-0002-4241-3749

Correspondence should be addressed to S Wang: shuwang999@hotmail.com

*(Y Wang, Z Jin and J Sun contributed equally to this work)

Restricted access

USD  $0.01
USD  $0.01

USD  $0.01
USD  $0.01

USD  $0.01
USD  $0.01

USD  $0.01
USD  $0.01

USD  $0.01
USD  $0.01

USD  $0.01
USD  $0.01

USD  $0.01
USD  $0.01

USD  $0.01
USD  $0.01

Graves’ disease (GD) is characterized by dysregulation of the immune system with aberrant immune cell function. However, there have been few previous studies on the role of monocytes in the pathology of GD. The object of this study was to investigate whether and how monocytes participate in GD pathology. CD14+ monocytes were isolated from untreated initial GD patients and healthy controls. Then, RNA-seq was performed to investigate changes in global mRNA expression in monocytes and found that type I interferon (IFN) signalling was among the top upregulated signalling pathways in GD monocytes. Type I IFN-induced sialic acid-binding immunoglobulin-like lectin1 (SIGLEC1) expression was significantly upregulated in untreated GD patients and correlated with thyroid parameters. Patient serum SIGLEC1 concentrations were reduced after anti-thyroid drug treatment. Inhibiting SIGLEC1 expression could inhibit proinflammatory cytokine (IL-1β, IL-6, IL-8, IL-10 and M-CSF) expression in monocytes. In conclusion, our study suggested that type I IFN-mediated monocyte activation could have a deleterious effect on the pathogenesis of GD. These observations indicated that the inhibition of type I IFN-activated monocytes/macrophages could have a therapeutic effect on GD remission.

 

  • Collapse
  • Expand

Society for Endocrinology logo

  • Banchereau J & Pascual V 2006 Type I interferon in systemic lupus erythematosus and other autoimmune diseases. Immunity 25 383392. (https://doi.org/10.1016/j.immuni.2006.08.010)

    • Crossref
    • Search Google Scholar
    • Export Citation
  • Bao G, Han Z, Yan Z, Wang Q, Zhou Y, Yao D, Gu M, Chen B, Chen S, Deng A, et al.2010 Increased Siglec-1 expression in monocytes of patients with primary biliary cirrhosis. Immunological Investigations 39 645660. (https://doi.org/10.3109/08820139.2010.485625)

    • Crossref
    • Search Google Scholar
    • Export Citation
  • Blanco P, Palucka AK, Gill M, Pascual V & Banchereau J 2001 Induction of dendritic cell differentiation by IFN-alpha in systemic lupus erythematosus. Science 294 15401543. (https://doi.org/10.1126/science.1064890)

    • Crossref
    • Search Google Scholar
    • Export Citation
  • Caselli E, D'Accolti M, Soffritti I, Zatelli MC, Rossi R, Degli Uberti E & Di Luca D 2017 HHV-6A in vitro infection of thyrocytes and T cells alters the expression of miRNA associated to autoimmune thyroiditis. Virology Journal 14 3. (https://doi.org/10.1186/s12985-016-0672-6)

    • Search Google Scholar
    • Export Citation
  • Chen X, Wang Y, Qi Y, Yan J, Huang F, Zhou M, Wang W, Ning G, Zhou Y & Wang S 2021 Expansion of inflammatory monocytes in periphery and infiltrated into thyroid tissue in Graves’ disease. Scientific Reports 11 13443. (https://doi.org/10.1038/s41598-021-92737-4)

    • Search Google Scholar
    • Export Citation
  • Chuluundorj D, Harding SA, Abernethy D & La Flamme AC 2014 Expansion and preferential activation of the CD14(+)CD16(+) monocyte subset during multiple sclerosis. Immunology and Cell Biology 92 509517. (https://doi.org/10.1038/icb.2014.15)

    • Crossref
    • Search Google Scholar
    • Export Citation
  • Cox SN, Serino G, Sallustio F, Blasi A, Rossini M, Pesce F & Schena FP 2015 Altered monocyte expression and expansion of non-classical monocyte subset in IgA nephropathy patients. Nephrology, Dialysis, Transplantation 30 11221232. (https://doi.org/10.1093/ndt/gfv017)

    • Crossref
    • Search Google Scholar
    • Export Citation
  • Davies TF, Andersen S, Latif R, Nagayama Y, Barbesino G, Brito M, Eckstein AK, Stagnaro-Green A & Kahaly GJ 2020 Graves’ disease. Nature Reviews: Disease Primers 6 52. (https://doi.org/10.1038/s41572-020-0184-y)

    • Search Google Scholar
    • Export Citation
  • Estruch M, Rajamäki K, Sanchez-Quesada JL, Kovanen PT, Öörni K, Benitez S & Ordoñez-Llanos J 2015 Electronegative LDL induces priming and inflammasome activation leading to IL-1β release in human monocytes and macrophages. Biochimica et Biophysica Acta 1851 14421449. (https://doi.org/10.1016/j.bbalip.2015.08.009)

    • Crossref
    • Search Google Scholar
    • Export Citation
  • Faustino LC, Lombardi A, Madrigal-Matute J, Owen RP, Libutti SK & Tomer Y 2018 Interferon-α triggers autoimmune thyroid diseases via lysosomal-dependent degradation of thyroglobulin. Journal of Clinical Endocrinology and Metabolism 103 36783687. (https://doi.org/10.1210/jc.2018-00541)

    • Crossref
    • Search Google Scholar
    • Export Citation
  • Ferrari SM, Fallahi P, Elia G, Ragusa F, Camastra S, Paparo SR, Giusti C, Gonnella D, Ruffilli I, Shoenfeld Y, et al.2020 Novel therapies for thyroid autoimmune diseases: an update. Best Practice and Research: Clinical Endocrinology and Metabolism 34 101366. (https://doi.org/10.1016/j.beem.2019.101366)

    • Search Google Scholar
    • Export Citation
  • Gaidt MM, Ebert TS, Chauhan D, Schmidt T, Schmid-Burgk JL, Rapino F, Robertson AA, Cooper MA, Graf T & Hornung V 2016 Human monocytes engage an alternative inflammasome pathway. Immunity 44 833846. (https://doi.org/10.1016/j.immuni.2016.01.012)

    • Crossref
    • Search Google Scholar
    • Export Citation
  • Hammerstad SS, Stefan M, Blackard J, Owen RP, Lee HJ, Concepcion E, Yi Z, Zhang W & Tomer Y 2017 Hepatitis C virus E2 protein induces upregulation of IL-8 pathways and production of heat shock proteins in human thyroid cells. Journal of Clinical Endocrinology and Metabolism 102 689697. (https://doi.org/10.1210/jc.2016-3403)

    • Crossref
    • Search Google Scholar
    • Export Citation
  • Hammerstad SS, Blackard JT, Lombardi A, Owen RP, Concepcion E, Yi Z, Zhang W & Tomer Y 2020 Hepatitis C virus infection of human thyrocytes: metabolic, hormonal, and immunological implications. Journal of Clinical Endocrinology and Metabolism 105 11571168. (https://doi.org/10.1210/clinem/dgz241)

    • Crossref
    • Search Google Scholar
    • Export Citation
  • Hashimoto K, Nishihara E, Matsumoto M, Matsumoto S, Nakajima Y, Tsujimoto K, Yamakage H, Satoh-Asahara N, Noh JY, Ito K, et al.2018 Sialic acid-binding immunoglobulin-like Lectin1 as a novel predictive biomarker for relapse in Graves’ disease: a multicenter study. Thyroid 28 5059. (https://doi.org/10.1089/thy.2017.0244)

    • Crossref
    • Search Google Scholar
    • Export Citation
  • Hohl TM, Rivera A, Lipuma L, Gallegos A, Shi C, Mack M & Pamer EG 2009 Inflammatory monocytes facilitate adaptive CD4 T cell responses during respiratory fungal infection. Cell Host and Microbe 6 470481. (https://doi.org/10.1016/j.chom.2009.10.007)

    • Crossref
    • Search Google Scholar
    • Export Citation
  • Karlmark KR, Tacke F & Dunay IR 2012 Monocytes in health and disease – minireview. European Journal of Microbiology and Immunology 2 97102. (https://doi.org/10.1556/EuJMI.2.2012.2.1)

    • Crossref
    • Search Google Scholar
    • Export Citation
  • Kuang M, Wang S, Wu M, Ning G, Yao Z & Li L 2010 Expression of IFNalpha-inducible genes and modulation of HLA-DR and thyroid stimulating hormone receptors in Graves’ disease. Molecular and Cellular Endocrinology 319 2329. (https://doi.org/10.1016/j.mce.2009.12.006)

    • Crossref
    • Search Google Scholar
    • Export Citation
  • Mao C, Wang S, Xiao Y, Xu J, Jiang Q, Jin M, Jiang X, Guo H, Ning G & Zhang Y 2011 Impairment of regulatory capacity of CD4+CD25+ regulatory T cells mediated by dendritic cell polarization and hyperthyroidism in Graves’ disease. Journal of Immunology 186 47344743. (https://doi.org/10.4049/jimmunol.0904135)

    • Crossref
    • Search Google Scholar
    • Export Citation
  • Masters SL, Simon A, Aksentijevich I & Kastner DL 2009 Horror autoinflammaticus: the molecular pathophysiology of autoinflammatory disease. Annual Review of Immunology 27 621668. (https://doi.org/10.1146/annurev.immunol.25.022106.141627)

    • Crossref
    • Search Google Scholar
    • Export Citation
  • O’Neill AS, van den Berg TK & Mullen GE 2013 Sialoadhesin – a macrophage-restricted marker of immunoregulation and inflammation. Immunology 138 198207. (https://doi.org/10.1111/imm.12042)

    • Crossref
    • Search Google Scholar
    • Export Citation
  • Qi Y, Zhou Y, Chen X, Ye L, Zhang Q, Huang F, Cui B, Lin D, Ning G, Wang W, et al.2017 MicroRNA-4443 causes CD4+ T cells dysfunction by targeting TNFR-associated factor 4 in Graves’ disease. Frontiers in Immunology 8 14401440. (https://doi.org/10.3389/fimmu.2017.01440)

    • Crossref
    • Search Google Scholar
    • Export Citation
  • Rönnblom L & Eloranta ML 2013 The interferon signature in autoimmune diseases. Current Opinion in Rheumatology 25 248253. (https://doi.org/10.1097/BOR.0b013e32835c7e32)

    • Crossref
    • Search Google Scholar
    • Export Citation
  • Rossol M, Kraus S, Pierer M, Baerwald C & Wagner U 2012 The CD14(bright) CD16+ monocyte subset is expanded in rheumatoid arthritis and promotes expansion of the Th17 cell population. Arthritis and Rheumatism 64 671677. (https://doi.org/10.1002/art.33418)

    • Crossref
    • Search Google Scholar
    • Export Citation
  • Smith TJ & Hegedüs L 2016 Graves’ disease. New England Journal of Medicine 375 15521565. (https://doi.org/10.1056/NEJMra1510030)

  • Taylor PN, Albrecht D, Scholz A, Gutierrez-Buey G, Lazarus JH, Dayan CM & Okosieme OE 2018 Global epidemiology of hyperthyroidism and hypothyroidism. Nature Reviews: Endocrinology 14 301316. (https://doi.org/10.1038/nrendo.2018.18)

    • Search Google Scholar
    • Export Citation
  • Weider T, Richardson SJ, Morgan NG, Paulsen TH, Dahl-Jørgensen K & Hammerstad SS 2021 HLA Class I upregulation and antiviral immune responses in Graves disease. Journal of Clinical Endocrinology and Metabolism 106 17631774. (https://doi.org/10.1210/clinem/dgaa958)

    • Crossref
    • Search Google Scholar
    • Export Citation
  • Xiong YS, Zhou YH, Rong GH, Wu WL, Liang Y, Yang ZX, Geng HL & Zhong RQ 2009 Siglec-1 on monocytes is a potential risk marker for monitoring disease severity in coronary artery disease. Clinical Biochemistry 42 10571063. (https://doi.org/10.1016/j.clinbiochem.2009.02.026)

    • Crossref
    • Search Google Scholar
    • Export Citation
  • Xiong YS, Cheng Y, Lin QS, Wu AL, Yu J, Li C, Sun Y, Zhong RQ & Wu LJ 2014 Increased expression of Siglec-1 on peripheral blood monocytes and its role in mononuclear cell reactivity to autoantigen in rheumatoid arthritis. Rheumatology 53 250259. (https://doi.org/10.1093/rheumatology/ket342)

    • Crossref
    • Search Google Scholar
    • Export Citation
  • Yin X, Sachidanandam R, Morshed S, Latif R, Shi R & Davies TF 2014 mRNA-Seq reveals novel molecular mechanisms and a robust fingerprint in Graves’ disease. Journal of Clinical Endocrinology and Metabolism 99 E2076E2083. (https://doi.org/10.1210/jc.2014-1735)

    • Crossref
    • Search Google Scholar
    • Export Citation
  • York MR, Nagai T, Mangini AJ, Lemaire R, van Seventer JM & Lafyatis R 2007 A macrophage marker, siglec-1, is increased on circulating monocytes in patients with systemic sclerosis and induced by type I interferons and toll-like receptor agonists. Arthritis and Rheumatism 56 10101020. (https://doi.org/10.1002/art.22382)

    • Crossref
    • Search Google Scholar
    • Export Citation
  • Ziegler-Heitbrock L & Hofer TP 2013 Toward a refined definition of monocyte subsets. Frontiers in Immunology 4 23. (https://doi.org/10.3389/fimmu.2013.00023)

    • Search Google Scholar
    • Export Citation
  • Ziegler-Heitbrock L, Ancuta P, Crowe S, Dalod M, Grau V, Hart DN, Leenen PJM, Liu YJ, MacPherson G, Randolph GJ, et al.2010 Nomenclature of monocytes and dendritic cells in blood. Blood 116 e74e80. (https://doi.org/10.1182/blood-2010-02-258558)

    • Crossref
    • Search Google Scholar
    • Export Citation